Home688319 • SHA
add
Chengdu Olymvax Biopharmaceuticals Inc
Previous close
¥31.18
Day range
¥30.18 - ¥32.29
Year range
¥12.45 - ¥34.68
Market cap
10.99B CNY
Avg Volume
6.20M
P/E ratio
193.37
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 197.24M | -2.46% |
Operating expense | 262.44M | 52.61% |
Net income | -25.25M | -250.90% |
Net profit margin | -12.80 | -254.78% |
Earnings per share | — | — |
EBITDA | -23.22M | -183.24% |
Effective tax rate | -4.44% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 217.27M | -10.09% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 968.34M | — |
Shares outstanding | 405.71M | — |
Price to book | 13.21 | — |
Return on assets | — | — |
Return on capital | -5.53% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -25.25M | -250.90% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Dec 11, 2009
Website
Employees
463
